Style | Citing Format |
---|---|
MLA | Varshosaz J, et al.. "Synthesis of Octadecylamine-Retinoic Acid Conjugate for Enhanced Cytotoxic Effects of 5-Fu Using Ldl Targeted Nanostructured Lipid Carriers." European Journal of Medicinal Chemistry, vol. 54, no. , 2012, pp. 429-438. |
APA | Varshosaz J, Hassanzadeh F, Sadeghi H, Andalib S (2012). Synthesis of Octadecylamine-Retinoic Acid Conjugate for Enhanced Cytotoxic Effects of 5-Fu Using Ldl Targeted Nanostructured Lipid Carriers. European Journal of Medicinal Chemistry, 54(), 429-438. |
Chicago | Varshosaz J, Hassanzadeh F, Sadeghi H, Andalib S. "Synthesis of Octadecylamine-Retinoic Acid Conjugate for Enhanced Cytotoxic Effects of 5-Fu Using Ldl Targeted Nanostructured Lipid Carriers." European Journal of Medicinal Chemistry 54, no. (2012): 429-438. |
Harvard | Varshosaz J et al. (2012) 'Synthesis of Octadecylamine-Retinoic Acid Conjugate for Enhanced Cytotoxic Effects of 5-Fu Using Ldl Targeted Nanostructured Lipid Carriers', European Journal of Medicinal Chemistry, 54(), pp. 429-438. |
Vancouver | Varshosaz J, Hassanzadeh F, Sadeghi H, Andalib S. Synthesis of Octadecylamine-Retinoic Acid Conjugate for Enhanced Cytotoxic Effects of 5-Fu Using Ldl Targeted Nanostructured Lipid Carriers. European Journal of Medicinal Chemistry. 2012;54():429-438. |
BibTex | @article{ author = {Varshosaz J and Hassanzadeh F and Sadeghi H and Andalib S}, title = {Synthesis of Octadecylamine-Retinoic Acid Conjugate for Enhanced Cytotoxic Effects of 5-Fu Using Ldl Targeted Nanostructured Lipid Carriers}, journal = {European Journal of Medicinal Chemistry}, volume = {54}, number = {}, pages = {429-438}, year = {2012} } |
RIS | TY - JOUR AU - Varshosaz J AU - Hassanzadeh F AU - Sadeghi H AU - Andalib S TI - Synthesis of Octadecylamine-Retinoic Acid Conjugate for Enhanced Cytotoxic Effects of 5-Fu Using Ldl Targeted Nanostructured Lipid Carriers JO - European Journal of Medicinal Chemistry VL - 54 IS - SP - 429 EP - 438 PY - 2012 ER - |